{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:51:36Z","timestamp":1792011096022,"version":"4.4.0"},"publisher-location":"Chichester, UK","reference-count":45,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001287","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:16:04Z","timestamp":1069384564000},"source":"Crossref","is-referenced-by-count":20,"title":["Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease"],"prefix":"10.1002","author":[{"given":"PJ","family":"Poole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PN","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,1,20]]},"reference":[{"key":"10.1002\/14651858.CD001287-BIB1|cit1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000196540","article-title":"Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial","volume":"63","author":"Allegra","year":"1996","journal-title":"Respiration"},{"issue":"suppl. 111","key":"10.1002\/14651858.CD001287-BIB2|cit2","first-page":"93","article-title":"Long-term oral acetylcysteine in chronic bronchitis. A double-blind controlled study","volume":"61","year":"1980","journal-title":"European Journal of Respiratory Disease"},{"key":"10.1002\/14651858.CD001287-BIB3|cit3","first-page":"405","article-title":"Oral acetylcysteine reduces exacerbation rate in chronic bronchitis; report of a trial organized by the Swedish Society for Pulmonary Diseases","volume":"64","author":"Boman","year":"1983","journal-title":"European Journal of Respiratory Disease"},{"key":"10.1002\/14651858.CD001287-BIB4|cit4","first-page":"155","article-title":"Clinical effectiveness and tolerance of cithiolone in the prophylaxis of acute infective exacerbations in patients suffering from chronic bronchitis","volume":"17","author":"Bontognali","year":"1991","journal-title":"Acta Therapeutica"},{"key":"10.1002\/14651858.CD001287-BIB5|cit5","first-page":"467","article-title":"Confronto tra acetilcisteina e placebo nel trattamento a lungo termine della bronchite cronica","volume":"140","author":"Borgia","year":"1981","journal-title":"Gaz Med It"},{"key":"10.1002\/14651858.CD001287-BIB6|cit6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000194928","article-title":"Effect of long-term treatment with sobrerol on the exacerbations of chronic bronchitis","volume":"50","author":"Castiglioni","year":"1986","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD001287-BIB7|cit7","first-page":"715","article-title":"Long-term treatment of chronic bronchitis for two years with ambroxol (Mucosolvan) retard capsules. Results of a double blind trial including 180 patients","volume":"42","author":"Cegla","year":"1988","journal-title":"Prax. Klin. Pneumol"},{"key":"10.1002\/14651858.CD001287-BIB8|cit8","first-page":"121","article-title":"I farmaci attivi sul muco nel trattamento di fondo della bronchite cronica","volume":"116","author":"Cremonini","year":"1986","journal-title":"Clin Ter"},{"key":"10.1002\/14651858.CD001287-BIB9|cit9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1034\/j.1399-3003.1999.13d22.x","volume":"13","author":"Ekberg-Jansson","year":"1999","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001287-BIB10|cit10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00606554","article-title":"A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis","volume":"9","author":"Grassi","year":"1976","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD001287-BIB11|cit11","first-page":"17","article-title":"Terapia intervallare con l'associazione carbocisteina-sobrerolo nella profilassi delle riacutizzazioni della bronchite cronica","volume":"48","author":"Grassi","year":"1994","journal-title":"Italian Journal of Chest Disease"},{"key":"10.1002\/14651858.CD001287-BIB12|cit12","first-page":"395","article-title":"Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control","volume":"October","author":"Grillage","year":"1985","journal-title":"British Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD001287-BIB13|cit13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0954-6111(05)80337-3","article-title":"Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis","volume":"88","author":"Hansen","year":"1994","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD001287-BIB14|cit14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/030006058401200312","article-title":"Efficacy and tolerability of oral acetylcysteine (fabrol) in chronic bronchitis: a double-blind placebo controlled trial","volume":"12","author":"Jackson","year":"1984","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD001287-BIB15|cit15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/thx.40.11.832","article-title":"Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction","volume":"40","year":"1985","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD001287-BIB16|cit16","unstructured":"Meister R Long-term therapy with acetylcysteine retard tablets in patients with chronic bronchitis:a double-blind. placebo controlled study"},{"issue":"4","key":"10.1002\/14651858.CD001287-BIB17|cit17","first-page":"351","article-title":"Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators","volume":"49","author":"Meister","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1002\/14651858.CD001287-BIB18|cit18","first-page":"381s","article-title":"Long-term administration of N-acetylcysteine reduces the number of acute exacerbation episodes in subjects with chronic obstructive pulmonary disease:report of the BREATHE study","volume":"14","author":"Nowak","year":"1999","journal-title":"European Respiratory Journal"},{"issue":"suppl 1","key":"10.1002\/14651858.CD001287-BIB19|cit19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000195274","article-title":"Ambroxol for the prevention of chronic bronchitis exacerbations:long-term multicenter trial","volume":"51","author":"Olivieri","year":"1987","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD001287-BIB20|cit20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0007-0971(87)90182-3","article-title":"Oral fabrol (oral n-acetyl-cysteine) in chronic bronchitis","volume":"81","author":"Parr","year":"1987","journal-title":"British Journal of Diseases of the Chest"},{"key":"10.1002\/14651858.CD001287-BIB21|cit21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000029447","article-title":"N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD","volume":"66","author":"Pela","year":"1999","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD001287-BIB23|cit22","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1378\/chest.97.2.24S","article-title":"Summary of the national mucolytic study","volume":"97","author":"Morgan","year":"1990","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001287-BIB22|cit23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1378\/chest.97.1.75","article-title":"The national mucolytic study: results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis","volume":"97","author":"Petty","year":"1990","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001287-BIB24|cit24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1183\/09031936.93.01040351","article-title":"Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis","volume":"1","author":"Rasmussen","year":"1988","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD001287-BIB26|cit25","first-page":"69","article-title":"Mucolytic treatment of chronic bronchitis during two winter periods","volume":"90","author":"Andreasen","year":"1974","journal-title":"Scandinavian Journal of Respiratory Disease"},{"key":"10.1002\/14651858.CD001287-BIB25|cit26","first-page":"48","article-title":"Mucolytic treatment of chronic bronchitis during two winter periods","volume":"52","author":"Christensen","year":"1971","journal-title":"Scandinavian Journal of Respiratory Disease"},{"key":"10.1002\/14651858.CD001287-BIB27|cit27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1378\/chest.70.4.506","article-title":"S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction","volume":"70","author":"Edwards","year":"1976","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD001287-BIB28|cit28","first-page":"356","article-title":"Chronic obstructive lung diseases:the efficacy of cineole","volume":"44","author":"Habich","year":"1994","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD001287-BIB29|cit29","first-page":"110","article-title":"Treatment of chronic bronchitis with oral acetylcysteine, a double-blind study","volume":"61","author":"Maesen","year":"1980","journal-title":"European Journal of Respiratory Disease"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001287-BIB30|cit30","first-page":"90","article-title":"Assessment of efficacy and tolerability of the oral treatment of ambrosol in patients with chronic bronchitis","volume":"64","author":"Michnar","year":"1996","journal-title":"Pneumonol alergol pol"},{"key":"10.1002\/14651858.CD001287-BIB31|cit31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1378\/chest.109.2.348","article-title":"Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis","volume":"109","author":"Rubin","year":"1996","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001287-BIB32|cit32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1183\/09031936.01.17303290","volume":"17","author":"Decramer","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1002\/14651858.CD001287-BIB33|cit33","article-title":"Mucolytic treatment of chronic bronchitis during two winter periods. Scand J Respir Dis 1974","author":"Andreasen"},{"key":"10.1002\/14651858.CD001287-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.320.7245.1297","article-title":"Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial","volume":"320","author":"Jones","year":"2000","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001287-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1164\/ajrccm.156.6.9612096","article-title":"Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease","volume":"156","author":"Collet","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/14651858.CD001287-BIB36|cit36","first-page":"318","article-title":"Long-term acetylcysteine in chronic bronchitis:pointers from a randomized multi-centre trial. British Journal of Diseases of the Chest 1980;?","volume":"?","author":"Ferrari"},{"key":"10.1002\/14651858.CD001287-BIB37|cit37","doi-asserted-by":"crossref","unstructured":"Pauwels RA Buist AS Calverley PM Jenkins C Hurd SS Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO workshop report Bethesda MD National Institutes of Health Heart, Lung, and Blood Institute 2001 100","DOI":"10.1164\/ajrccm.163.5.2101039"},{"issue":"2","key":"10.1002\/14651858.CD001287-BIB38|cit38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0149-2918(00)88479-9","article-title":"Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials","volume":"22","author":"Grandjean","year":"2000","journal-title":"Clin Ther"},{"issue":"1","key":"10.1002\/14651858.CD001287-BIB39|cit39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/phrs.1999.0647","article-title":"Cost-effectiveness analysis of oral N-acetylcysteine as a preventive treatment in chronic bronchitis","volume":"42","author":"Grandjean","year":"2000","journal-title":"Pharmacol Res"},{"key":"10.1002\/14651858.CD001287-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomised controlled trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001287-BIB41|cit41","doi-asserted-by":"crossref","first-page":"24s","DOI":"10.1378\/chest.97.2_Supplement.24S","article-title":"Summary of the national mucolytic study","volume":"97","author":"Morgan","year":"1990","journal-title":"Chest"},{"key":"10.1002\/14651858.CD001287-BIB42|cit42","doi-asserted-by":"crossref","unstructured":"Medical Research Council Definition and classification of chronic bronchitis for clinical and epidemiological purposes 1965 775 81","DOI":"10.1016\/S0140-6736(65)92953-3"},{"key":"10.1002\/14651858.CD001287-BIB43|cit43","article-title":"Epidemiology of COPD","volume-title":"Chronic Obstructive Pulmonary Disease","author":"Redline","year":"1991"},{"key":"10.1002\/14651858.CD001287-BIB44|cit44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1034\/j.1399-3003.2000.16b12.x","article-title":"The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review","volume":"16","author":"Stey","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1002\/14651858.CD001287-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.322.7297.1271","article-title":"Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease:systematic review","volume":"322","author":"Poole","year":"2001","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T13:07:18Z","timestamp":1704978438000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001287"}},"subtitle":[],"editor":[{"given":"Phillippa","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2003,1,20]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001287","relation":{},"subject":[],"published":{"date-parts":[[2003,1,20]]}}}